chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with stable COPD, with stable disease in the past 4 weeks without acute exacerbation; 2. Pulmonary function classification of the severity of airflow limitation: GOLD 1-3 3. Symptom assessment and risk of acute exacerbation: Groups A and B; 4. Aged 40 to 80 years, both male and female; 5. No history of infection or aggravation of respiratory symptoms, no drug changes within 3 months before the start of the study, and no symptoms of edema; 6. Patients who can walk independently; 7. Patients who have not undergone pulmonary rehabilitation in the past 6 months; 8. Good compliance, willing to cooperate with the research, and the patients signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Combined with severe cardiovascular and cerebrovascular, nervous system, blood system, immune system, digestive system, thyroid dysfunction, chronic liver and kidney insufficiency, malignant tumor; 2. Other concomitant active or clinically significant respiratory diseases that have a significant impact on the study: such as subjects with active pulmonary tuberculosis, bronchiectasis, pulmonary hypertension, pulmonary interstitial disease or other active pulmonary diseases; 3. Those who use long-term oxygen therapy (oxygen therapy time > 15h/d) or mechanical ventilation; 4. Those who are not satisfied with blood pressure and blood sugar control; 5. Those with a history of mental illness, mental retardation, and mobility impairment; 6. Pregnant or lactating women; 7. Those who have participated in other clinical trials within the past 6 months or at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lung function;Borg dyspnea scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| COPD assessment test;6-minute walk distance; | — |
Countries
China
Contacts
Chengdu University of Traditional Chinese Medicine